China Biologic Products Announces 2009 First Quarter Results Conference Call
May 18 2009 - 6:00AM
PR Newswire (US)
TAI'AN CITY, Shandong, China, May 18 /PRNewswire-Asia-FirstCall/ --
China Biologic Products, Inc. (OTC:CBPO) (BULLETIN BOARD: CBPO)
("CBP," or the "Company"), one of the leading plasma-based
pharmaceutical companies in the People's Republic of China ("PRC"),
today announced that it will host a conference call at 8:00 a.m.
EDT on Tuesday, May 19, 2009, to discuss the 2009 first quarter
financial results. Hosting the call will be Mr. Colin Zhao, Chief
Executive Officer, and Mr. Tristan Kuo, Chief Financial Officer. To
participate in the live conference call, please dial the following
number five to ten minutes prior to the scheduled conference call
time: 888- 419-5570. International callers should dial
617-896-9871. The pass code for the call is 634 701 69. If you are
unable to participate in the call at this time, a replay will be
available for 14 days starting on Tuesday, May 19, 2009 at 10:00
a.m. EDT. To access the replay, dial 888-286-8010, international
callers should dial 617-801-6888. The conference pass code is 373
105 74. About China Biologic Products, Inc. China Biologic
Products, Inc. (the "Company"), through its indirect majority-owned
subsidiary, Shandong Taibang Biological Products Co. Ltd., and
equity investments in Xi'an Huitian Blood Products Co., Ltd. and
Chongqing Dalin Biologic Technologies Co., Ltd. is currently the
largest non-state-owned plasma-based biopharmaceutical company
approved by the Chinese government. The Company is a fully
integrated biologic products company with plasma collection,
production and manufacturing, research and development, and
commercial operations. The Company's blood products are
irreplaceable in the application of medical emergencies, and
prevention and treatment for various diseases. It sells its
plasma-based biopharmaceutical products to hospitals and other
healthcare facilities in China. For more information, please
contact: Company Contact: Mr. Y. Tristan Kuo CFO China Biologic
Products, Inc. Tel: +86-538-6202206 Email: Web:
http://www.chinabiologic.com/ Investor Relations Contact: Mr.
Crocker Coulson, President CCG Investor Relations Tel:
+1-646-213-1915 (NY office), or Mr. Gary Chin Tel: +1-646-213-1909
Email: Web: http://www.ccgirasia.com/ DATASOURCE: China Biologic
Products, Inc. CONTACT: Company Contact: Mr. Y. Tristan Kuo, CFO of
China Biologic Products, Inc., +86-538-6202206, or ; Or Investor
Relations Contact: Mr. Crocker Coulson, President of CCG Investor
Relations, +1-646-213-1915 (NY office), or Mr. Gary Chin,
+1-646-213-1909, or Web site: http://www.chinabiologic.com/
http://www.ccgirasia.com/
Copyright